DIAXONHIT has a total of 15 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ORYZON GENOMICS SA, INST MED BIOTECHNOLOGY CAMS and ORION YHTYMAE OY.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | EAPO (Eurasian Patent Organization) | 1 | |
#7 | Hong Kong | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Desire Laurent | 6 |
#2 | Leblond Bertrand | 6 |
#3 | Foucourt Alicia | 6 |
#4 | Besson Thierry | 6 |
#5 | Casagrande Anne-Sophie | 5 |
#6 | Mignon Godefroy Karine | 3 |
#7 | Beurdeley Pascale | 3 |
#8 | Nuyttens Hélène | 3 |
#9 | Thomas Damien | 3 |
#10 | Rogé Julie | 3 |
Publication | Filing date | Title |
---|---|---|
EP3034620A1 | Compositions and methods for diagnosing thyroid cancer | |
CA2848896A1 | Dyrk1 inhibitors and uses thereof | |
EP2594580A1 | Method for diagnosing propionibacterium bacteria infections |